New research could help in the treatment of cardiovascular disease

February 21, 2011, University of Bristol
New research could help in the treatment of cardiovascular disease

Cardiovascular disease can occur when vascular smooth muscle cells (VSMC) increase causing artery walls to thicken as the result of a build-up of fatty materials such as cholesterol.  Researchers have demonstrated that the Wnt/β-catenin signaling pathway plays a key role in encouraging the growth of VSMC in vivo.  These new findings could help in the treatment of cardiovascular disease.

The study by Sarah George, Professor of Cardiovascular Signalling and colleagues in the School of Clinical Sciences at the University of Bristol was funded by the British Heart Foundation and is published online in the Journal of the American Heart Association, Circulation Research.

Previous studies suggest the involvement of the Wnt/β-catenin signalling pathway in VSMC growth and the thickening of the inner layer of blood vessels has been merely ‘guilt by association’ and no direct proof has been available.

The researchers have found direct evidence that Wnt/β-catenin signalling pathway encourages an increase in VSMC in vivo. In addition, they have demonstrated for the first time both in vitro and in vivo that the protein, Wnt4, is specifically up-regulated by growth factors and helps VSMC growth and activation of the canonical Wnt/β-catenin pathway through the protein, Frizzled receptor.

At the level of basic science, the findings provide a greater understanding of the control of VSMC increase by growth factors and identify Frizzled-1 as the predominant Wnt4 receptor in this cell type. Additionally, the researchers have revealed Wnt4 and Frizzled-1 as potential targets for new therapeutics to slow down VSMC growth in order to delay the thickening of the inner layer of and thereby hardening of the arteries (atherosclerosis) and the reoccurance of the narrowing of a blood vessel (restenosis).

Professor George said: “Understanding the mechanisms underlying the increase in VSMC may aid the development of new therapeutic approaches to prevent artery walls thickening and help with cardiovascular disease.”

, including heart attack and stroke is the number one killer in the UK and western world.  It is caused by the pathology known as atherosclerosis and leads to blockage of arteries.  Patients with arterial blockages are treated with vein grafts and implantation of stents. Unfortunately these treatments suffer high failure rates (30-50 per cent) within ten years leading to further clinical burden.  Treatment failure is caused by thickening of the inner layer (intima) of blood vessel as a result of an increase in the resident cells (VSMCs) in the blood vessel wall.

More information: Wnt4/β-Catenin Signaling Induces VSMC Proliferation and Is Associated With Intimal Thickening, Aikaterini Tsaousi, et al. Circulation Research, published online December 30, 2010.

Related Stories

Recommended for you

Human 'chimeric' cells restore crucial protein in Duchenne muscular dystrophy

March 16, 2018
Cells made by fusing a normal human muscle cell with a muscle cell from a person with Duchenne muscular dystrophy —a rare but fatal form of muscular dystrophy—were able to significantly improve muscle function when implanted ...

Team develops 3-D tissue model of a developing human heart

March 16, 2018
The heart is the first organ to develop in the womb and the first cause of concern for many parents.

Democratizing science: Researchers make neuroscience experiments easier to share, reproduce

March 16, 2018
Over the past few years, scientists have faced a problem: They often cannot reproduce the results of experiments done by themselves or their peers.

Genetic variant discovery to help asthma sufferers

March 16, 2018
Research from the University of Liverpool, published today in Lancet Respiratory Medicine, identifies a genetic variant that could improve the safety and effectiveness of corticosteroids, drugs that are used to treat a range ...

Researchers say use of artificial intelligence in medicine raises ethical questions

March 15, 2018
In a perspective piece, Stanford researchers discuss the ethical implications of using machine-learning tools in making health care decisions for patients.

Study identifies potential drug for treatment of debilitating inherited neurological disease

March 15, 2018
St. Jude Children's Research Hospital scientists have demonstrated in mouse studies that the neurological disease spinal bulbar muscular atrophy (SBMA) can be successfully treated with drugs. The finding paves the way for ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.